Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

PROVISIONAL BEST PRACTICES GUIDELINES FOR THE EVALUATION OF BULBAR DYSFUNCTION IN ALS.

Pattee GL, Plowman EK, Garand KLF, Costello J, Brooks BR, Berry JD, Smith RA, Atassi N, Chapin JL, Yunusova Y, McIlduff CE, Young E, Macklin EA, Locatelli ER, Silani V, Heitzman D, Wymer J, Goutman SA, Gelinas DF, Perry B, Nalipinski P, Stipancic K, O'Brien M, Sullivan SL, Pioro EP, Gargiulo G, Green JR; Contributing Members of the NEALS Bulbar Subcommittee.

Muscle Nerve. 2019 Jan 8. doi: 10.1002/mus.26408. [Epub ahead of print]

PMID:
30620104
2.

Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering.

Tang M, Gao C, Goutman SA, Kalinin A, Mukherjee B, Guan Y, Dinov ID.

Neuroinformatics. 2018 Nov 20. doi: 10.1007/s12021-018-9406-9. [Epub ahead of print]

PMID:
30460455
3.

Amyotrophic lateral sclerosis-specific quality of life-short form (ALSSQOL-SF): A brief, reliable, and valid version of the ALSSQOL-R.

Felgoise SH, Feinberg R, Stephens HE, Barkhaus P, Boylan K, Caress J, Clawson LL, Elman L, Goutman SA, Mccluskey L, Russell J, Tiryaki E, Weiss M, Simmons Z.

Muscle Nerve. 2018 Nov;58(5):646-654. doi: 10.1002/mus.26203. Epub 2018 Oct 19.

PMID:
30028537
4.

Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS.

Goutman SA, Brown MB, Glass JD, Boulis NM, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges L, Patil PG, Sakowski SA, Feldman EL.

Ann Clin Transl Neurol. 2018 May 2;5(6):730-740. doi: 10.1002/acn3.567. eCollection 2018 Jun.

5.

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A; ITALSGEN Consortium, Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L; Genomic Translation for ALS Care (GTAC) Consortium, Moreno CAM, Kamalakaran S, Goldstein DB; ALS Sequencing Consortium, Gitler AD, Harris T, Myers RM; NYGC ALS Consortium, Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC; Answer ALS Foundation, Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J; SLAGEN Consortium, Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C; French ALS Consortium, Corcia P, Laaksovirta H, Myllykangas L, Jansson L, Valori M, Ealing J, Hamdalla H, Rollinson S, Pickering-Brown S, Orrell RW, Sidle KC, Malaspina A, Hardy J, Singleton AB, Johnson JO, Arepalli S, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Al-Sarraj S, King A, Troakes C, Vance C, de Belleroche J, Baas F, Ten Asbroek ALMA, Muñoz-Blanco JL, Hernandez DG, Ding J, Gibbs JR, Scholz SW, Floeter MK, Campbell RH, Landi F, Bowser R, Pulst SM, Ravits JM, MacGowan DJL, Kirby J, Pioro EP, Pamphlett R, Broach J, Gerhard G, Dunckley TL, Brady CB, Kowall NW, Troncoso JC, Le Ber I, Mouzat K, Lumbroso S, Heiman-Patterson TD, Kamel F, Van Den Bosch L, Baloh RH, Strom TM, Meitinger T, Shatunov A, Van Eijk KR, de Carvalho M, Kooyman M, Middelkoop B, Moisse M, McLaughlin RL, Van Es MA, Weber M, Boylan KB, Van Blitterswijk M, Rademakers R, Morrison KE, Basak AN, Mora JS, Drory VE, Shaw PJ, Turner MR, Talbot K, Hardiman O, Williams KL, Fifita JA, Nicholson GA, Blair IP, Rouleau GA, Esteban-Pérez J, García-Redondo A, Al-Chalabi A; Project MinE ALS Sequencing Consortium, Rogaeva E, Zinman L, Ostrow LW, Maragakis NJ, Rothstein JD, Simmons Z, Cooper-Knock J, Brice A, Goutman SA, Feldman EL, Gibson SB, Taroni F, Ratti A, Gellera C, Van Damme P, Robberecht W, Fratta P, Sabatelli M, Lunetta C, Ludolph AC, Andersen PM, Weishaupt JH, Camu W, Trojanowski JQ, Van Deerlin VM, Brown RH Jr, van den Berg LH, Veldink JH, Harms MB, Glass JD, Stone DJ, Tienari P, Silani V, Chiò A, Shaw CE, Traynor BJ, Landers JE.

Neuron. 2018 Mar 21;97(6):1268-1283.e6. doi: 10.1016/j.neuron.2018.02.027.

PMID:
29566793
6.

Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis.

Goutman SA, Chen KS, Paez-Colasante X, Feldman EL.

Handb Clin Neurol. 2018;148:603-623. doi: 10.1016/B978-0-444-64076-5.00039-9. Review.

PMID:
29478603
7.

Complete hazard ranking to analyze right-censored data: An ALS survival study.

Huang Z, Zhang H, Boss J, Goutman SA, Mukherjee B, Dinov ID, Guan Y; Pooled Resource Open-Access ALS Clinical Trials Consortium.

PLoS Comput Biol. 2017 Dec 18;13(12):e1005887. doi: 10.1371/journal.pcbi.1005887. eCollection 2017 Dec.

8.

Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposium.

Pattee GL, Plowman EK, Brooks BR, Berry JD, Atassi N, Chapin JL, Garand K, Yunusova Y, Mcilduff CE, Young E, Costello JM, Macklin EA, Locatelli ER, Silani V, Heitzman D, Wymer J, Goutman SA, Gelinas DF, Smith R, Perry B, Nalipinski P, Stipancic K, O'Brien M, Sullivan SL, Green J; CONTRIBUTING MEMBERS OF THE NEALS BULBAR SUBCOMMITTEE.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):311-312. doi: 10.1080/21678421.2017.1404109. Epub 2017 Dec 5.

PMID:
29205054
9.

Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.

Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL.

JAMA Neurol. 2017 Dec 1;74(12):1446-1454. doi: 10.1001/jamaneurol.2017.2255.

10.

Diagnosis and Clinical Management of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders.

Goutman SA.

Continuum (Minneap Minn). 2017 Oct;23(5, Peripheral Nerve and Motor Neuron Disorders):1332-1359. doi: 10.1212/CON.0000000000000535. Review.

PMID:
28968365
11.

Symptom management in amyotrophic lateral sclerosis: We can do better.

Goutman SA, Simmons Z.

Muscle Nerve. 2018 Jan;57(1):1-3. doi: 10.1002/mus.25740. Epub 2017 Aug 30. No abstract available.

12.

Use of Angle-Independent M-Mode Sonography for Assessment of Diaphragm Displacement.

Goutman SA, Hamilton JD, Rubin JM.

J Ultrasound Med. 2017 Jun;36(6):1285. doi: 10.1002/jum.14204. No abstract available.

13.

Speckle tracking as a method to measure hemidiaphragm excursion.

Goutman SA, Hamilton JD, Swihart B, Foerster B, Feldman EL, Rubin JM.

Muscle Nerve. 2017 Jan;55(1):125-127. doi: 10.1002/mus.25380. Epub 2016 Aug 22.

14.

Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials.

Glass JD, Hertzberg VS, Boulis NM, Riley J, Federici T, Polak M, Bordeau J, Fournier C, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges LF, Rutkove SB, Duell J, Patil PG, Goutman SA, Feldman EL.

Neurology. 2016 Jul 26;87(4):392-400. doi: 10.1212/WNL.0000000000002889. Epub 2016 Jun 29. Erratum in: Neurology. 2017 Aug 1;89(5):521.

15.

Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis.

Murdock BJ, Bender DE, Kashlan SR, Figueroa-Romero C, Backus C, Callaghan BC, Goutman SA, Feldman EL.

Neurol Neuroimmunol Neuroinflamm. 2016 Jun 1;3(4):e242. doi: 10.1212/NXI.0000000000000242. eCollection 2016 Aug.

16.

Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci.

He F, Jones JM, Figueroa-Romero C, Zhang D, Feldman EL, Goutman SA, Meisler MH, Callaghan BC, Todd PK.

Neurol Genet. 2016 May 11;2(3):e71. doi: 10.1212/NXG.0000000000000071. eCollection 2016 Jun.

17.

Association of Environmental Toxins With Amyotrophic Lateral Sclerosis.

Su FC, Goutman SA, Chernyak S, Mukherjee B, Callaghan BC, Batterman S, Feldman EL.

JAMA Neurol. 2016 Jul 1;73(7):803-11. doi: 10.1001/jamaneurol.2016.0594. Erratum in: JAMA Neurol. 2017 May 1;74(5):612.

18.

Pearls & Oy-sters: The importance of atypical features and tracking progression in patients misdiagnosed with ALS.

Jacobson RD, Goutman SA, Callaghan BC.

Neurology. 2016 Mar 29;86(13):e136-9. doi: 10.1212/WNL.0000000000002522. No abstract available.

19.

Clinical Trials of Therapies for Amyotrophic Lateral Sclerosis: One Size Does Not Fit All.

Goutman SA, Feldman EL.

JAMA Neurol. 2015 Jul;72(7):743-4. doi: 10.1001/jamaneurol.2014.4275. Review. No abstract available.

20.

Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL.

Nat Rev Neurol. 2015 May;11(5):266-79. doi: 10.1038/nrneurol.2015.57. Epub 2015 Apr 21. Review.

PMID:
25896087

Supplemental Content

Loading ...
Support Center